RE:RE:RE:RE: 05 September new RioGlio/ Pelareorep Article The comparative data is separate to the following Short et al. study abstract. which I provided it to show some further context to the results presented by the ReoGlio investigators.
.A. LONG-TERM FOLLOW UP AND TRANSLATIONAL DATA FROM THE REOGLIO PHASE IB TRIAL OF GM-CSF AND INTRAVENOUS PELAREOREP (REOVIRUS) ALONGSIDE STANDARD OF CARE IN GBM
S. Short1, J. Kendall1, E. West1, A. Chalmers2, C. McBain3, A. Melcher4, F. Collinson1, R. Phillip1, S. Brown1, A. Samson1;
1University of Leeds, Leeds, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3The Christie Hospital, Manchester, Manchester, United Kingdom, 4Institute of Cancer Research, London, United Kingdom.